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Mateusz Wierzbicki1, Ewa Sawosz1, Marta Grodzik1, Marta Prasek1, Slawomir Jaworski1 and André Chwalibog2*Abstract
Angiogenesis is vital for tumour formation, development and metastasis. Recent reports show that carbon
nanomaterials inhibit various angiogenic signalling pathways and, therefore, can be potentially used in
anti-angiogenic therapy. In the present study, we compared the effect of different carbon nanomaterials on blood
vessel development. Diamond nanoparticles, graphite nanoparticles, graphene nanosheets, multi-wall nanotubes
and C60 fullerenes were evaluated for their angiogenic activities using the in ovo chick embryo chorioallantoic
membrane model. Diamond nanoparticles and multi-wall nanotubes showed the greatest anti-angiogenic
properties. Interestingly, fullerene exhibited the opposite effect, increasing blood vessel development, while
graphite nanoparticles and graphene had no effect. Subsequently, protein levels of pro-angiogenic growth factor
receptors were analysed, showing that diamond nanoparticles decreased the expression of vascular endothelial
growth factor receptor. These results provide new insights into the biological activity of carbon nanomaterials and
emphasise the potential use of multi-wall nanotubes and diamond nanoparticles in anti-angiogenic tumour
therapy.
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Angiogenesis is the most common process of new blood
vessel development. Growth of new vessels starts from
pre-existing ones and consists of two main processes:
sprouting (endothelial cell migration) and intussusception
(splitting of vessels) [1,2]. The growth of blood vessels
depends on a balance between angiogenesis-promoting
and angiogenesis-inhibiting signalling molecules. Vascular
network growth is an essential process, especially during
embryonic development, tissue remodelling and regener-
ation. However, disorders in blood vessel development
may foster diseases like chronic inflammatory disorders.
Development of new vessels is also essential for the growth
and metastasis of tumours, in which pro-angiogenic
molecules like vascular endothelial growth factor
(VEGF) and fibroblast growth factor (FGF) play critical
roles. Binding of FGF and especially VEGF, which is
considered a major molecule controlling blood vessel
morphogenesis, to their tyrosine kinase receptors activates* Correspondence: ach@sund.ku.dk
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in any medium, provided the original work is pmultiple downstream molecules involved in different
signalling pathways that lead to increased vascular
permeability, cell migration and proliferation [3]. The VEGF
receptor KDR (also called Flk-1) and the FGF receptor
FGFR are responsible for regulating angiogenesis (for
reviews, see [4,5]).
Therapeutic anti-angiogenic compounds have been
extensively studied for anti-tumour therapy. VEGF
inhibitors have been approved for clinical use in cancer
diseases. However, anti-VEGF therapy is effective only in
particular cases and can lead to serious toxicity [6,7].
Angiogenesis is a complex process regulated by several
regulators. Inhibiting only the VEGF signalling pathway
seems to be insufficient. Hence, therapeutic agents
affecting tumour cells without harming healthy cells
are necessary to optimise cancer treatments. Carbon
nanomaterials can be used as low-toxicity inhibitors
of tumour angiogenesis. It has been demonstrated that
nanoparticles of diamond, graphite, graphene, nanotubes
and fullerenes display low toxicity [8-11]. Recently, we
showed that diamond nanoparticles and microwave-
radiofrequency carbon decreased the vascular network
in glioblastoma tumours and mRNA levels of VEGFAis an Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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surface-to-volume ratio, carbon nanomaterials cause high
biological activity and enable easy surface modification
[13,14]. We hypothesised that pristine carbon nanoparticles
can affect VEGF and bFGF receptors and inhibit tumour
angiogenesis, but the effectiveness of anti-angiogenic
activity can vary between different carbon nanostructures.
Consequently, the objective of this study was to
explore the anti-angiogenic properties of different
carbon nanomaterials to find the most efficient for
anti-angiogenic tumour therapy.
Methods
Nanomaterials
In the present study, we used in ovo chicken embryo
chorioallantoic membranes (CAM) to compare the anti-
angiogenic properties of pristine carbon nanomaterials:
diamond nanoparticles (ND), graphite nanoparticles (NG),
graphene nanosheets (GNS), multi-wall nanotubes (MWNT)
and C60 fullerenes (C60). The physical characteristics of
the nanoparticles are given in Table 1. ND and NG are
spherical nanoparticles, produced by the detonation method
with size ranging from 3 to 4 nm. C60 is a spherical
nanoparticle that in water solvent aggregates into particles
with a mean size of approximately 50 nm. GNS and
MWNT are nanomaterials having diameters of 6 to 8 nm
and 8 nm, and length of approximately 15 μm and 5 to 20
μm, respectively. Purity and specific surface area (except
C60) were provided by the manufacturers. C60 was
obtained from SES Research (Houston, TX, USA), and all
other materials were from Skyspring Nanomaterials
(Houston, TX, USA). The nanomaterials were dispersed in
demineralised water using sonication. New solutions were
made a day before each repetition. The shape and size of
the nanomaterials were visualised using a JEM-2000EX
transmission electron microscope (JEOL Ltd., Tokyo,
Japan) at 200 kV (Figure 1). Zeta potential measurements
were carried out on a Zetasizer Nano-ZS90 (Malvern,
Worcestershire, UK) at 25°C. Measurements were
conducted using Smoluchowski approximation, whichTable 1 Comparison of the physical characteristics of the carb
GNS NG
Shape Nanosheet Spherical nanoparticle Spheric
Size 6 to 8 nm/15 μm 3 to 4 nm 3
Atom configuration sp2 sp2
Purity >99.5% >93%
Zeta potential (mV) −3.83 28.7
Specific surface area 120 to 150 m2/g 540 to 650 m2/g Approxim
Production Exfoliated Explosion E
Purity and specific surface area (except C60) were provided by the manufacturer. Th
electron microscope. Zeta potential was examined with Zetasizer Nano-ZS90. GNS,
C60, fullerene C60; MWNT, multi-wall nanotube; CVD, chemical vapour deposition. ais rigorously valid only for spherical particles. Therefore,
the zeta potential of non-spherical nanomaterials may be
overestimated by up to 20% [15].
CAM assay
CAM implants were made from sterile Waterman filter
paper with a diameter of 10 mm. Water (control) or
hydrocolloids of nanoparticles of a concentration of 500
mg/L were added to the implants (final amount of
nanoparticles on the implant was 0.01 mg). The implants
were pre-treated with 3 mg/mL of hydrocortisone sodium
succinate (Sigma, St. Louis, MO, USA) and air dried under
sterile conditions. Fertilised eggs from Ross line 308 hens
were obtained from a certified hatchery and kept for 4
days at 12°C. The eggs were cleaned, sterilised with UVC
light and divided into six groups (6 × 20 eggs). Embryos
were incubated at standard conditions (temperature 37°C,
humidity 60% and turned once per hour). Embryonic
day 0 (E0) started when the eggs were placed into the
incubator. At day E6, small holes (1 cm2) were made on
the shell above air space, the inner membrane was gently
stripped off, and the implants were placed on CAM. The
chicken embryos were incubated until day 7 of embryonic
development, when implants with CAM were prefixed
with 1.5 mL of 4% paraformaldehyde. After 30 min of
incubation at 4°C, CAM with implants were cut out and
fixed at 4°C in 4% paraformaldehyde for 60 min (total
fixation time, 90 min). After fixation, the implants were
gently stripped off. All measurements were repeated three
times minimum.
CAM tissue angiogenesis analysis
The methodology of quantifying blood vessel development
was based on [17] and [18], validated and used for this in-
vestigation. CAM tissues from implants were investigated
with a stereomicroscope under a 12.5-fold magnification
(SZX10, CellD software version 3.1, Olympus Corpor-
ation, Tokyo, Japan). Photos were analysed with CellSens
Dimension Desktop version 1.3 (Olympus Corporation).
The level of angiogenesis in eight CAM tissues from eachon nanoparticles
ND C60 MWNT
al nanoparticle Spherical nanoparticle Multi-wall tube
to 4 nm Approximately 50 nm (aggregates) 8 nm/5 to 20 μm
sp3 sp2 sp2
>95% >99.5% >95%
−39.3 −38.0 −14.8
ately 282 m2/g 0.07 to 0.17 m2/ga >500 m2/g
xplosion Arc discharge Catalytic CVD
e size was provided by the manufacturer and examined with a transmission
graphene nanosheet; NG, graphite nanoparticle; ND, diamond nanoparticle;
Taken from Cheng et al. [16].
Figure 1 Transmission electron microscopic images of carbon nanomaterials. (A) GNS, (B) NG, (C) ND, (D) C60 and (E) MWNT.
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length and number of branch points on three square areas
of dimensions 2.5 × 2.5 mm (total area, 18.75 mm2 out of
78.5 mm2). CAM tissue areas were selected semi-randomly
so that the vessels with a diameter greater than 200 μm
were not assessed. Vessel area, length and number of
branch points were calculated separately for vessels
with a diameter smaller than 100 μm and those between
100 and 200 μm. To calculate the vessel area, the intensity
differences between vessels and background were in-
creased. Local contrast of images was strengthened by
increasing the intensity by 20 and brightness by 300Figure 2 CAM assay for determining total area of vessels with CellSen
dimensions 2.5 × 2.5 mm and (B) image with a strengthened local contras
calculation, the threshold was set at intensity volumes between 0 and 256(kernel radius, 128). The threshold was set at intensity
volumes between 0 and 256 for shades of red, 0 and 256
for green, and 0 and 145 for blue (Figure 2).CAM tissue morphological analysis
CAM implant morphology and development of capillary
vessels were determined with the stereomicroscope
described above. CAM cross sections were made with a
cryostat (CM 1900, Leica, Wetzlar, Germany). Blocks
were cut into 5-μm-thick sections and observed under a
light microscope (DM 750, Leica).s Dimension Desktop version 1.3. (A) CAM square area of
t of images by increasing intensity and brightness. (C) For total area
for the shades of red, 0 and 256 for green, 0 and 145 and for blue.
Table 2 Comparison of angiogenesis parameters of vessels
with a diameter between 100 and 200 μm
Mean vessel
area (mm2)
Mean vessel
length (mm)
Number of
branch points
Angiogenic
activity
Group
Control 30.8 2.8 a 4.3 a
GNS 26.9 2.3 ab 4.2 ab 0
NG 24.9 2.0 ab 2.6 ab 0
ND 25.9 1.9 b 1.8 b - -
C60 39.4 2.7 a 3.8 ab 0
MWNT 25.4 1.7 b 3.4 ab - -
P value 0.038 0.006 0.014
Pooled SE 3.5 0.2 0.5
A 0 means no activity, a hyphen indicates low anti-angiogenic activity, and
two hyphens indicate medium anti-angiogenic activity. Values with different
letters are significantly different, P < 0.05. SE, standard error; GNS, graphene
nanosheets; NG, graphite nanoparticle; ND, diamond nanoparticle; C60,
fullerene C60; MWNT, multi-wall nanotube.
Table 3 Comparison of angiogenesis parameters of vessels
with a diameter less than 100 μm
Mean vessel
area (mm2)
Mean vessel
length (mm)
Number of
branch points
Angiogenic
activity
Group
Control 44.9 a 9.9 a 11.4 a
GNS 50.0 a 9.9 a 13.4 ab + (tendency)
NG 47.5 a 9.1 ab 10.1 a 0
ND 33.1 b 7.7 b 5.5 c - -
C60 52.1 a 11.9 c 14.7 b +++
MWNT 46.2 a 8.7 ab 9.1 d - -
P value 0.004 0.000 0.000
Pooled SE 3.1 0.4 0.7
A 0 means no activity; a plus sign indicates low pro-angiogenic activity; three
plus signs indicate high pro-angiogenic activity; two hyphens indicate medium
anti-angiogenic activity; and three hyphens indicate high anti-angiogenic
activity. Values with different letters are significantly different, P < 0.05. SE,
standard error; GNS, graphene nanosheet; NG, graphite nanoparticle; ND,
diamond nanoparticle; C60, fullerene C60; MWNT, multi-wall nanotube.
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Protein levels of CAM KDR and FGFR were examined
by Western blot analysis. Protein extracts were prepared
with TissueLyser LT (Qiagen, Hilden, Germany) using
ice-cold RIPA buffer (150 mM NaCl, 0.5% sodium
deoxycholate, 1% NP-40, 0.1% SDS, 50 mM Tris, pH
7.4) with protease and phosphatase inhibitors (Sigma).
The protein concentration was determined by the Total
Protein Kit, Micro Lowry, Peterson's Modification (Sigma).
An equal volume (50 mg) of samples was denatured by
the addition of sample buffer (Bio-Rad Laboratories,
Munich, Germany) and boiled for 4 min. Proteins were
resolved under reductive conditions with SDS-PAGE
and transferred onto PVDF membrane (Life Technologies,
Gaithersburg, MD, USA). Protein bands were visualised
with the GelDoc scanner (Bio-Rad Laboratories), using
the fluorescent method of the WesternDot Kit (Life
Technologies) and the primary antibodies bGFR (cat.
no. F4305-08, USBiological, Swampscott, MA, USA),
KDR (cat. no. SAB4300356, Sigma) and GAPDH (cat. no.
NB300-327, Novus Biologicals, Cambridge, UK) as loading
control (dilutions recommended by the producers).
Protein bands were characterised using the Quantity One
1-D analysis software (Bio-Rad Laboratories).
Statistical analysis
A one-way analysis of variance with the Bonferroni post
hoc test was used for multiple comparisons. Differences at
P < 0.05 were considered significant. Results are shown as
means and standard errors.
Results
We compared the influence of different carbon nanoparticles
on the development of blood vessels, using the chicken
embryo CAM implantation method as a model for
angiogenesis [19]. The experiments were repeated three
times minimum, and all repetitions gave equivalent
results. Changes in the development of blood vessels
after nanoparticle treatments were observed by measuring
changes in the mean vessel area, vessel length and the
number of branch points. These parameters were investi-
gated in vessels at two development states: older with a
diameter between 100 and 200 μm and newly developed
with a diameter smaller than 100 μm. The area of blood
vessels with a diameter between 100 and 200 μm was the
largest in the C60-treated group. However, these
changes were not statistically significant (Table 2).
Vessel length decreased after MWNT and ND treatment.
Both nanoparticles caused a comparable decrease in blood
vessel length. Of all the investigated nanoparticles, only
ND significantly decreased the number of branch points.
Assessment of the development of vessels with a diameter
smaller than 100 μm showed different results. The area of
newly developed vessels treated with ND was significantlysmaller, compared to the other groups (Table 3). Both ND
and MWNT decreased vessel length and the number of
branch points, but ND had a significantly stronger effect.
Furthermore, capillary vessels of MWNT- and especially
ND-treated implants were poorly developed (Figure 3).
Vessel branching was also affected by C60, resulting in an
increased number of vessel branch points. NG and GNS
showed no effect on the examined parameters in both
older and newly formed vessels.
To confirm whether nanoparticles affected CAM
morphology, we investigated CAM cross sections
(Figure 4). In the control group, the mean CAM
thickness varied between 250 and 380 μm. In the
ND- and MWNT-treated groups, the mean thickness
varied between 80 and 200 μm and 90 and 260 μm,
Figure 3 CAM vessel morphology in response to treatment with carbon nanoparticles. (A) Control, (B) GNS, (C) NG, (D) ND, (E) C60 and
(F) MWNT. Scale bar, 500 μm.
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CAM morphology.
Expression of KDR correlated with the pro- and anti-
angiogenic properties of C60 and ND, but not MWNT
(Table 4, Figure 5). Compared to the control group, ND
reduced the expression of KDR by 38%. Fullerenes
increased the KDR protein level by 30%. The other
tested nanoparticles did not significantly alter the protein
levels of KDR. FGFR protein amounts were not affected
by all the tested carbon nanoparticles.
Discussion
In this work, we compared the anti-angiogenic properties
of carbon-based nanomaterials. The measurements were
performed using the well-established chicken embryo
CAM model [17,19]. CAM growth is essential for embryo
development and is almost complete by 1 to 14 days of
embryogenesis [20]. Blood vessel development was exam-
ined in the phase of the most intensive vessel growth,
which was on day 7 of chicken embryo development [21].
The present results are consistent with our previous
research, demonstrating that ND and microwave-radio-
frequency carbon allotrope decreased the vascular
network in glioblastoma tumour and, consequently, their
volume and weight. Moreover, diamond nanoparticlesdecreased the mRNA level of the main pro-angiogenic
factors VEGFA and bFGF [12]. ND also affected the
transcription level of the human stress-responsive
genes of cells exposed to stress (heat shock, cytotoxic
and oxidative stress). It has been demonstrated that
although ND did not show toxic effects on leukaemia
cell line HL-60, it up-regulates the expression of the
gene SOD1, responsible for the defence mechanism
against reactive oxygen species, and down-regulates
the genes JUN, GADD45A and FRAP1, responsible for
protection against genotoxic and cellular stress [22].
Moreover, the anti-angiogenic activity of nanoparticles has
been related to their inhibitory effects on pro-angiogenic
factors. Gold nanoparticles specifically bind to VEGFA
and bFGF and inhibit their interaction with cell membrane
receptors [23,24].
Among all the tested nanoparticles, only MWNT and
more significantly ND showed anti-angiogenic activity.
Nanomaterials with graphite structure (NG and GNS)
did not alter blood vessel development. There are only a
few studies on the biological activity of GNS. Wang
et al. [25] showed that GNS oxide exhibited low toxicity
in mice and human fibroblast cells. Furthermore, GNS
displayed low cytotoxicity in erythrocytes and fibroblasts
[26], which together with our results suggests that GNS
Figure 4 Cross sections of CAM tissue treated with carbon nanoparticles. (A) Control, (B) GNS, (C) NG, (D) ND, (E) C60 and (F) MWNT. Scale
bar, 100 μm.
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NG had no effect on CAM angiogenesis, although they
have the same shape and similar size and are produced in
the same way (but under different conditions) as ND [27],
which had the strongest anti-angiogenic activity (Table 1).
The strongest inhibition of vessel growth by ND may
be linked to the inhibition of VEGF receptor (KDR)
expression. VEGF is a major pro-angiogenic factor essential
for the development of the blood vessel network. It is
controlled by the release of growth factors dependent
on the oxygen level, with HIF-1 being one of the most
important [3]. Hypoxia leads to the up-regulation of VEGF
and, thus, the formation of new blood vessels, whichTable 4 Relative percentage of KDR and FGFR protein levels c
Protein
Groups
Control (%) GNS (%) NG (%) ND (%
KDR 100.0 a 102.1 a 103.3 a 62.0 b
FGFR 100.0 ab 96.0 a 103.6 ab 95.3 a
Values with different letters are significantly different, P < 0.05. ANOVA, analysis of
nanoparticle; ND, diamond nanoparticle; C60, fullerene C60; MWNT, multi-wall nano
factor receptor; GAPDH, glyceraldehyde-3-phosphate dehydrogenase.consequently normalises the oxygen status. In tumours,
high activity and fast divisions of tumour cells lead to
oxygen deficiency that enhances vessel growth. KDR is
also regulated by various signalling molecules in response
to changes in oxygen concentration [28,29]. Hypoxia leads
to KDR up-regulation and activation of the angiogenic
signalling cascade [30,31]. Down-regulation of KDR by
ND may decrease hypoxia-mediated angiogenesis and
exert efficient and long-lasting anti-angiogenic effects.
Moreover, chronic hypoxia can lead to further down-
regulation of KDR [32]. MWNT showed anti-angiogenic
activity, inhibiting the branching of vessels with a diameter
smaller than 100 μm. This indicates that MWNT inhibitsalculated with GAPDH as the loading control
ANOVA
) C60 (%) MWNT (%) P value Pooled SE
129.6 c 102.7 a 0.000 2.4
108.3 b 104.2 ab 0.000 2.0
variance; SE, standard error; GNS, graphene nanosheet; NG, graphite
tube; KDR, vascular endothelial growth factor receptor; FGFR, fibroblast growth
Figure 5 Representative immunoblot of KDR and FGFR CAM
protein expression levels examined by Western blotting. GNS,
graphene nanosheet; NG, graphite nanoparticle; ND, diamond
nanoparticle; C60, fullerene C60; MWNT, multi-wall nanotube; KDR,
vascular endothelial growth factor receptor; FGFR, fibroblast growth
factor receptor; GAPDH, glyceraldehyde-3-phosphate dehydrogenase.
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report is consistent with the results of another study
showing that pristine MWNT displayed an anti-angiogenic
effect on an in vivo VEGFA/bFGF-induced model [33] and
in in vitro HUVEC tubule formation assays [34]. However,
doxorubicin conjugated with single-wall nanotubes had
the opposite effects [35].
As expected, nanoparticles had less impact on the
development of older vessels. Only ND, which exerted the
strongest anti-angiogenic properties, induced a significant
decrease in vessel length and the number of branch
points. However, ND did not change the area of older
vessels (100 to 200 μm). Reduced length and branching
without significant changes in vessel area suggest that
ND can inhibit the development of vessels with dimensions
that slightly exceed 100 μm and smaller. The present
results give new insights into the bioactive properties of
ND and clearly show that this carbon nanoparticle can be
considered for use in low-toxicity anti-angiogenic therapy.
Interestingly, our results demonstrated pro-angiogenic
activity of pristine C60, which increased the number of
branch points and vessel length. Fullerene C60 has been
used to inhibit cancer growth [36] and is used as
photosensitisers in photodynamic therapy [37]. However,
Zogovic et al. [38] studied the effect of nanocrystaline
fullerene on melanoma tumour and showed that fullerene,
probably by immunosuppression, had tumour-promoting
activity and increased the production of nitric oxide (NO),
which can promote angiogenesis [39]. Furthermore, other
reactive oxygen species can also induce angiogenesis [40].
The ability of C60 to generate reactive oxygen species
has been previously demonstrated [41,42]. NO promotes
angiogenesis by up-regulating the expression of the
VEGFA receptor [43], which is consistent with our report.
This appears to be the most probable mechanism
underlying fullerene pro-angiogenic effects and may only
be specific for pristine nanoparticles. Hydroxylated C60
has been shown to protect cells in vitro form oxidative
stress, while pristine nanoparticles show pro-oxidantcapacity [44,45]. Moreover, C60 modified with multi-
hydroxylated metal can simultaneously down-regulate
more than ten angiogenic factors and significantly
decrease the capillary vessels of tumours (average size 1.2
cm in diameter) [46]. Murugesan et al. [33] demonstrated
that pristine MWNT and C60 inhibited the angiogenesis
induced by exogenous VEGFA or bFGF. Our results
indicated that C60 had the opposite effect on vessels not
stimulated by exogenous pro-angiogenic factors. This
suggests that C60 can have both anti- and pro-angiogenic
activity depending on the physiological state of blood
vessels.
Conclusions
We compared the anti-angiogenic properties of pristine
carbon nanomaterials. According to our results, the
carbon nanomaterials showing the most anti-angiogenic
to pro-angiogenic properties were as follows: diamond
nanoparticles (anti-angiogenic) - multi-wall nanotubes -
graphite nanoparticles (no activity) - graphene
nanosheets - fullerene C60 (pro-angiogenic). Only dia-
mond nanoparticles, multi-wall nanotubes and fullerenes
showed statistically significant results. Nanoparticles
showing anti-angiogenic effects also changed the morph-
ology of CAM by decreasing its thickness. Diamond
nanoparticles and fullerene changed the expression level
of KDR, but not FGFR, thereby affecting the angiogenic
potential of CAM. Multi-wall nanotubes and especially
diamond nanoparticle can be considered potential
inhibitors of blood vessel growth in anti-angiogenic
tumour therapy.
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